Download the SAS Brochure
Friday, September 23
| 12:00 noon |
Registration and Exhibits Open/Lunch |
| 1:00 p.m. |
Welcome and Introductions |
| 1:10 p.m. |
The Great Debate: Instituting Myeloma Therapy: Synergy versus Sequence
Angela Dispenzieri, MD, Mayo Clinic in Rochester
Ruben Niesvizky, MD, The New York Presbyterian Hospital, Cornell University |
| 1:50 p.m. |
Amyloidosis: Isn't It The Same as Myeloma?
David Seldin, MD, PhD, Boston University School of Medicine |
| 2:30 p.m. |
Panel Discussion |
| 3:00 p.m. |
Break and Exhibits |
| 3:20 p.m. |
Monoclonal Gammopathy Consults: Wielding One's Way Between Monoclonal Gammopathy Associated Neuropathy, Nephropathy, and Dermopathy
Ola Landgren, MD, PhD, National Cancer Institute, National Institutes of Health |
| 4:00 p.m. |
Relapsed Myeloma - What's New (and Old): Treatment and Supportive Care
James R. Berenson, MD, Institute for Myeloma and Bone Cancer Research |
| 4:40 p.m. |
Monoclonal B-cell Lymphocytosis and Chronic Lymphocytic Leukemia: Clinical and Diagnostic Implications
Jennifer R. Brown, MD, PhD, Dana-Farber Cancer Institute |
| 5:20 p.m. |
Panel Discussion |
| 5:50 p.m. |
Program Concludes for the Day |
Saturday, September 24
| 7:00 a.m. |
Breakfast with the Experts
(Speakers and Attendees) |
| 7:55 a.m. |
Introductions and Announcements |
| 8:00 a.m. |
Practice Update |
| 8:10 a.m. |
Use of Hematopoietic Growth Factors: When and Where?
Janice Gabrilove, MD, Mount Sinai Medical Center |
| 8:50 a.m. |
Breaking News: New Oral Anticoagulants - When and When Not to Use
Thomas L. Ortel, MD, PhD, Duke University Health System |
| 9:30 a.m. |
Panel Discussion |
| 10:00 a.m. |
Break and Exhibits Open |
| 10:20 a.m. |
Large Granular Lymphocyte Disorders
Thomas P. Loughran, Jr., MD, Penn State Hershey Cancer Institute |
| 11:00 a.m. |
New Treatment Approaches in Low Grade Lymphoma
Jonathan Friedberg, MD, James P. Wilmot Cancer Center, University of Rochester |
| 11:40 a.m. |
Hodgkin Lymphoma
Anas Younes, MD, M.D. Anderson Cancer Center |
| 12:20 p.m. |
Panel Discussion |
| 12:50 p.m. |
Lunch and Exhibits Open |
| 2:00 p.m. |
Acute Lymphocytic Leukemia
Anjali Advani, MD, Cleveland Clinic Foundation |
| 2:40 p.m. |
Molecular Profiling in Acute Myeloid Leukemia: Treatment Implications
Mark J. Levis, MD, PhD, Johns Hopkins University |
| 3:20 p.m. |
Novel Treatment Strategies in Myeloproliferative Disorders and Chronic Myeloid Leukemia
Ronald Hoffman, MD, Mount Sinai Medical Center |
| 4:00 p.m. |
Panel Discussion |
| 4:30 p.m. |
Symposium Adjourned |
back to top
